| Thomas M Schnatterbeck, PSYD | |
|
182 N Main St, Buffalo, WY 82834-1727 | |
| (307) 763-0123 | |
| (307) 684-9360 |
| Full Name | Thomas M Schnatterbeck |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 182 N Main St, Buffalo, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023045614 | NPI | - | NPPES |
| 21500 | Other | WY | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 442 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas M Schnatterbeck, PSYD 182 N Main St, Buffalo, WY 82834-1727 Ph: (307) 763-0123 | Thomas M Schnatterbeck, PSYD 182 N Main St, Buffalo, WY 82834-1727 Ph: (307) 763-0123 |
News Archive
The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper's authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.
The coronavirus pandemic is still rife – too many people are still becoming infected and dying every day. If the Government wants to set the country on the path to ‘normality', it must ensure that lockdown is eased safely and responsibly.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
Cephalon, Inc. today announced that the company received a second Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the supplemental new drug application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV] for the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel. In its letter to the company, the FDA reiterated its previously stated concerns regarding the NUVIGIL sNDA.
MagnaCare, a healthcare services company, today announced that it has earned Health Utilization Management Accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
› Verified 5 days ago
Dr. Theresa Anne Faulkner, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 135 Pine St, Suite B, Buffalo, WY 82834 Phone: 307-684-5828 Fax: 307-684-5803 | |
Dr. Kim Knox Faulkner, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 135 Pine Street, Suite B, Buffalo, WY 82834 Phone: 307-684-5828 Fax: 307-684-5803 | |
Dr. Timothy A Blaney, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 182 N Main St, Buffalo, WY 82834 Phone: 307-684-9360 Fax: 307-684-5187 |